Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s technical release/version label was updated from **v3.5.2** to **v3.5.3**, reflecting a platform update rather than any change to the study information.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to study content.SummaryDifference0.1%

- Check90 days agoChange DetectedA new Revision: v3.4.2 tag was added and the earlier Revision: v3.4.1 funding-status notice was removed, which are maintenance updates that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check97 days agoChange DetectedAdded a government funding lapse notice and NIH operations status; updated the site to version 3.4.1 and removed the 3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.